Right ventricular diastolic performance: compliance characteristics with focus on pulmonary hypertension, right ventricular hypertrophy, and calcium channel blockade.
Ferlinz
J
J
Department of Medicine, Aleda E. Lutz V.A. Medical Center, Saginaw, Michigan 48602, USA.
D000818:Animals; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications / Q000503:physiopathology; D003971:Diastole; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000503:physiopathology; D006976:Hypertension, Pulmonary / Q000150:complications / Q000503:physiopathology*; D017380:Hypertrophy, Right Ventricular / Q000150:complications / Q000503:physiopathology*; D008173:Lung Diseases, Obstructive / Q000150:complications / Q000503:physiopathology; D018497:Ventricular Dysfunction, Right / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology*; D016278:Ventricular Function, Right / Q000187:drug effects
D002121:Calcium Channel Blockers